semaglutide approved for obesity (wegovy) Weight Loss FDA Approves First ORAL GLP-1

Olubunmi Oladunjoye discusses GLP-1 medications for weight management, including their rise in popularity and possible side effects.

Significance statement ![Figure][1] ### Competing Interest Statement The authors have declared no competing interest

Even as weight-loss drugs such as Wegovy and Zepbound explode in popularity, many Americans struggle to afford them.

People using diabetes drugs such as Ozempic for weight loss are at higher risk of pancreatitis, bowel obstruction and stomach paralysis compared to those who use another medication approved specifically for obesity management, a University of British

Our patch supports this process by delivering targeted nutrients that help extend and enhance these effects, helping you feel satisfied longer and reducing the urge to overeat.*

Find upcoming conference details & earn CME/CE Credits.